NCT06679634View on ClinicalTrials.gov

Retinoblastoma Phase II Expanded Access Clinical Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 21, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Retinoblastoma
Interventions
DRUG

Chemoplaque also referred to as Episcleral Topotecan

Sustained Release Episcleral Topotecan

Trial Locations (1)

10032

RECRUITING

NewYork Presbyterian Morgan Stanley Children's Hospital, New York

All Listed Sponsors
collaborator

Morgan Stanley Children's Hospital

OTHER

lead

Targeted Therapy Technologies, LLC

INDUSTRY